本页面由Tiger Trade Technology Pte. Ltd.提供服务

Alpha Tau Medical

13.71
-0.5499-3.86%
成交量:35.57万
成交额:492.93万
市值:12.66亿
市盈率:-13.04
高:14.25
开:14.12
低:13.65
收:14.26
52周最高:15.79
52周最低:3.43
股本:9,233.29万
流通股本:6,379.44万
量比:0.93
换手率:0.56%
股息:- -
股息率:- -
每股收益(TTM):-1.0517
每股收益(LYR):-0.5300
净资产收益率:-141.68%
总资产收益率:-25.71%
市净率:28.73
市盈率(LYR):-25.87

数据加载中...

2025/06/30

SEC问询函

Form CORRESP - Correspondence
2025/03/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/12

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/07

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/12/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/20

SEC问询函

Form CORRESP - Correspondence
2023/06/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/04/11

SEC问询函

CORRESP [Cover] - Correspondence
2023/03/23

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/09

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/09

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/05/18

SEC问询函

CORRESP [Cover] - Correspondence
2022/05/03

SEC问询函

CORRESP [Cover] - Correspondence